Basic Materials / Specialty ChemicalsBSE
$1.29
+0.01 (+0.78%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $865.6M · quality 55.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.3B
P/E
21.5x
↑EV/EBITDA
6.7x
↓ROE
4.3%
↑Gross Margin
9.1%
↓Debt/Equity
0.07
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+18.2%
FCF CAGR
—
FCF margin
-17.3%
FCF / Net income
-3.86x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.78B · net income $169.8M · FCF $-654.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.78B | $3.78B | $2.59B | $3.94B | $2.29B |
| Net Income | $169.8M | $169.8M | $68.5M | $95.3M | $13.9M |
| EBITDA | $305.4M | $305.4M | $193.9M | $238.9M | $237.2M |
| EPS | 0.10 | 0.10 | 0.06 | 0.10 | 0.02 |
| Gross Margin | 9.1% | 9.1% | 13.0% | 7.5% | 5.1% |
| Operating Margin | 1.8% | 1.8% | 5.3% | 4.6% | 8.6% |
| Net Margin | 4.5% | 4.5% | 2.6% | 2.4% | 0.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.07 | 0.07 | 0.05 | 0.26 | 0.41 |
| Cash Flow | |||||
| Free Cash Flow | $-654.9M | $-654.9M | $1.15B | $865.6M | $-195.6M |
| Returns | |||||
| ROE | 4.3% | 4.3% | 1.8% | 4.0% | 0.6% |
| Valuation | |||||
| P/E | 21.50 | 21.50 | 70.17 | 27.60 | 283.00 |
| EV/EBITDA | 6.73 | 6.73 | 27.25 | 13.54 | 26.22 |
| P/B | 0.46 | 0.46 | 1.36 | 1.10 | 2.34 |
| Growth & Yield | |||||
| Revenue Growth | 46.0% | 46.0% | -34.3% | 71.9% | — |
| EPS Growth | 66.7% | 66.7% | -40.0% | 400.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
4.6%
EPS terminal req.
$0.11
Spread vs growth
62.1%
5Y implied EPS CAGR
6.7%
EPS terminal req.
$0.14
Spread vs growth
59.9%
10Y implied EPS CAGR
8.4%
EPS terminal req.
$0.22
Spread vs growth
58.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-44.6%
Start / end P/E
38.8x → 12.9x
EPS bridge
0.06 → 0.10
Residual
-44.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.